Lung Diseases, Obstructive: all 2,584 studies

Page 3 of 26. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Phase 4 COPD and Suboptimal Inspiratory Flow RateCompletedNCT05165485Phase 4Results posted
• Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT05046795Phase 3Results posted
• Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database StudyCompletedNCT04926233Results posted
• A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04923347Phase 4Results posted
• Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPDTerminatedNCT04921332Not applicableResults posted
• Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy SubjectsCompletedNCT04756960Phase 1Results posted
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin DeficiencyCompletedNCT04722887Phase 1/2Results posted
• Clinical Stabilization of Hypercapnia: NIPPV v HVNICompletedNCT04709562Not applicableResults posted
• Comparative Effectiveness of Telemedicine in Primary CareCompletedNCT04684836Results posted
• Cardio-pulmonary Rehabilitation and Sleep QualityCompletedNCT04668599Results posted
• A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisCompletedNCT04631016Phase 2Results posted
• Comparison of Time to Extubation Using Sugammadex or NeostigmineCompletedNCT04606901Phase 4Results posted
• A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and FormoterolCompletedNCT04600505Phase 1Results posted
• A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPDCompletedNCT04542057Phase 3Results posted
• A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPDCompletedNCT04535986Phase 3Results posted
• Rural Home Hospital: Proof of ConceptCompletedNCT04531280Not applicableResults posted
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationCompletedNCT04456673Phase 3Results posted
• Effect of Blood Flow Restriction Resistance Exercises in COPDAE In-patient RehabilitationCompletedNCT04448236Not applicableResults posted
• A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)TerminatedNCT04441788Phase 2Results posted
• EASiVENT Study Comparing INTELLiVENT-ASV vs Non Automated Ventilation in Adult ICU PatientsTerminatedNCT04400643Results posted
• A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care MedicationsTerminatedNCT04353661Phase 2Results posted
• Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT04268823Phase 2Results posted
• Vector Efficacy Cross-Over Pilot StudyTerminatedNCT04263532Results posted
• Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04169529Results posted
• A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.CompletedNCT04155047Phase 4Results posted
• Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicableResults posted
• Improving Patient Prioritization During Hospital-homecare TransitionCompletedNCT04136951Not applicableResults posted
• Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)CompletedNCT04107493Not applicableResults posted
• Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.CompletedNCT04078126Phase 3Results posted
• Tezepelumab COPD Exacerbation StudyCompletedNCT04039113Phase 2Results posted
• Uphill Walking as Exercise for COPD PatientsCompletedNCT04026529Not applicableResults posted
• A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA TreatmentCompletedNCT04011475Results posted
• A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03964207Phase 4Results posted
• Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)CompletedNCT03954132Results posted
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationCompletedNCT03930732Phase 3Results posted
• Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease PatientsTerminatedNCT03851510Results posted
• A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT03836677Phase 3Results posted
• A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With EosinophiliaTerminatedNCT03810183Phase 2Results posted
• Residential Cleaning of Indoor Air to Protect COPD PatientsCompletedNCT03750292Not applicableResults posted
• Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 2Results posted
• Metformin to Reduce Airway Glucose in COPD PatientsCompletedNCT03651895Phase 2Results posted
• A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.CompletedNCT03645434Phase 2Results posted
• The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)CompletedNCT03583099Not applicableResults posted
• A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPDCompletedNCT03573817Phase 3Results posted
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03546907Phase 2Results posted
• Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)TerminatedNCT03513068Not applicableResults posted
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03496623Phase 3Results posted
• Home Pulmonary Rehabilitation for COPDCompletedNCT03480386Not applicableResults posted
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478696Phase 4Results posted
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478683Phase 4Results posted
• A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03474081Phase 4Results posted
• Capnometry-Assisted Breathing Training for COPDCompletedNCT03457103Phase 2Results posted
• Integrated Care (IC) Models for Patient-Centered OutcomesCompletedNCT03451630Not applicableResults posted
• Monitoring and Peer Support to Improve Treatment Adherence and OutcomesCompletedNCT03446768Not applicableResults posted
• Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric SurgeryCompletedNCT03438383Not applicableResults posted
• Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 AgonistsCompletedNCT03405363Results posted
• Acupuncture Treatment of Chronic Obstructive Pulmonary Disease (COPD) ExacerbationCompletedNCT03398213Not applicableResults posted
• A Randomized Study to Evaluate the Effect of Reminder Notifications and Motivational/Adaptive Messaging on Treatment AdherenceTerminatedNCT03379233Phase 3Results posted
• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03345407Phase 2Results posted
• A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010CompletedNCT03311373Phase 1Results posted
• Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03276078Phase 2Results posted
• Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03256695Phase 3Results posted
• Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPDCompletedNCT03256552Phase 2Results posted
• Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03250689Phase 2Results posted
• A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat DoseCompletedNCT03250182Phase 1Results posted
• Belimumab Treatment of Emphysema Patients With Anti-GRP78 AutoantibodiesCompletedNCT03244059Phase 2Results posted
• The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusCompletedNCT03240575Phase 4Results posted
• Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the DrugCompletedNCT03235726Phase 1Results posted
• Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03227445Phase 4Results posted
• An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPDCompletedNCT03207776Not applicableResults posted
• Active for Life: Chronic Obstructive Pulmonary DiseaseCompletedNCT03201198Not applicableResults posted
• A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03170232Phase 2Results posted
• Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT03162055Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT03159091Phase 4Results posted
• Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia PacificCompletedNCT03151395Not applicableResults posted
• Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device RobustnessCompletedNCT03137992Phase 3Results posted
• Effects of Remote Patient Monitoring on Chronic Disease ManagementCompletedNCT03127852Not applicableResults posted
• Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03118765Phase 2Results posted
• Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPDCompletedNCT03095456Phase 3Results posted
• Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPDCompletedNCT03094806Not applicableResults posted
• Smart Telehealth Exercise Intervention to Reduce COPD ReadmissionsCompletedNCT03089853Not applicableResults posted
• The Topic Trial - Study to Determine the Safety and Efficacy of IvacaftorCompletedNCT03085485Phase 2Results posted
• A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT03084796Phase 2Results posted
• Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult SubjectsCompletedNCT03075267Phase 1Results posted
• Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03064113Phase 2Results posted
• Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03034967Phase 2Results posted
• A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03034915Phase 4Results posted
• The Effects of RPL554 in Addition to Tiotropium in COPD PatientsCompletedNCT03028142Phase 2Results posted
• Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin DeficiencyCompletedNCT03008915Phase 2Results posted
• A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02982187Phase 4Results posted
• Imaging of Peri-operative (periOP) Lung InjuryTerminatedNCT02978885Phase 2Results posted
• Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871CompletedNCT02971293Phase 2Results posted
• Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy VolunteersCompletedNCT02968914Phase 1Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02951312Phase 2Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02948582Phase 2Results posted
• A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPDCompletedNCT02937584Phase 3Results posted
• De-implementing Inhaled Steroids to Improve Care and Safety in COPDCompletedNCT02896257Not applicableResults posted
• Pulmonary Rehabilitation Before Lung Cancer ResectionTerminatedNCT02887521Phase 3Results posted
• RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedNCT02867761Phase 3Results posted
• Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02864407Results posted

← Lung Diseases, Obstructive overview